BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 29195803)

  • 1. [Validation of the French version of the self-evaluation of negative symptoms (SNS)].
    Hervochon C; Bourgeois V; Rotharmel M; Duboc JB; Le Goff B; Quesada P; Campion D; Dollfus S; Guillin O
    Encephale; 2018 Dec; 44(6):512-516. PubMed ID: 29195803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.
    Dollfus S; Mach C; Morello R
    Schizophr Bull; 2016 May; 42(3):571-8. PubMed ID: 26564898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polish version of the Self-evaluation of Negative Symptoms (SNS).
    Wójciak P; Górna K; Domowicz K; Jaracz K; Szpalik R; Michalak M; Rybakowski J
    Psychiatr Pol; 2019 Jun; 53(3):551-559. PubMed ID: 31522196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
    García-Álvarez L; Martínez-Cao C; Bobes-Bascarán T; Portilla A; Courtet P; de la Fuente-Tomás L; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):14-21. PubMed ID: 35256068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the lithuanian version of the self-evaluation of negative symptoms scale (SNS).
    Montvidas J; Adomaitienė V; Leskauskas D; Dollfus S
    Nord J Psychiatry; 2021 Jul; 75(5):351-355. PubMed ID: 33356749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Turkish version of the self-evaluation of negative symptoms scale (SNS).
    Polat I; Ince Guliyev E; Elmas S; Karakaş S; Aydemir Ö; Üçok A
    Int J Psychiatry Clin Pract; 2022 Sep; 26(3):221-227. PubMed ID: 35700173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and reliability of a Persian version of the self- evaluation of negative symptoms (SNS).
    Mazhari S; Karamooz A; Shahrbabaki ME; Jahanbakhsh F; Dollfus S
    BMC Psychiatry; 2021 Oct; 21(1):516. PubMed ID: 34666744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.
    Sarró S; Dueñas RM; Ramírez N; Arranz B; Martínez R; Sánchez JM; González JM; Saló L; Miralles L; San L
    Schizophr Res; 2004 Jun; 68(2-3):349-56. PubMed ID: 15099616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS).
    Goldring A; Borne S; Hefner A; Thanju A; Khan A; Lindenmayer JP
    Schizophr Res; 2020 Oct; 224():159-166. PubMed ID: 33071071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of a French translation of Krueger's personality inventory for DSM-5 in its brief form (PID-5 BF)].
    Combaluzier S; Gouvernet B; Menant F; Rezrazi A
    Encephale; 2018 Feb; 44(1):9-13. PubMed ID: 27692349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and reliability of a Chinese version of the self-evaluation of negative symptoms.
    Chen G; Chen J; Tian H; Lin C; Zhu J; Ping J; Chen L; Zhuo C; Jiang D
    Brain Behav; 2023 Apr; 13(4):e2924. PubMed ID: 36908244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychometric properties of French version of the Calgary depression scale for schizophrenics (CDSS)].
    Reine G; Bernard D; Auquier P; Le Fur B; Lançon C
    Encephale; 2000; 26(1):52-61. PubMed ID: 10875062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.
    Bischof M; Obermann C; Hartmann MN; Hager OM; Kirschner M; Kluge A; Strauss GP; Kaiser S
    BMC Psychiatry; 2016 Nov; 16(1):415. PubMed ID: 27876020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of depression in schizophrenia: psychometric properties of a French version of the Calgary Depression Scale.
    Lançon C; Auquier P; Reine G; Toumi M; Addington D
    Psychiatry Res; 1999 Dec; 89(2):123-32. PubMed ID: 10646831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of resistance to voices on depression].
    Monestès JL; Vavasseur-Desperriers J; Villatte M; Denizot L; Loas G; Rusinek S
    Encephale; 2015 Feb; 41(1):25-31. PubMed ID: 24815790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of mental states at risk of psychotic transition: validation of the French version of the CAARMS].
    Krebs MO; Magaud E; Willard D; Elkhazen C; Chauchot F; Gut A; Morvan Y; Bourdel MC; Kazes M
    Encephale; 2014 Dec; 40(6):447-56. PubMed ID: 25127895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
    García-Álvarez L; Martínez-Cao C; Bobes-Bascarán T; Portilla A; Courtet P; de la Fuente-Tomás L; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2020 Jun; ():. PubMed ID: 32517967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Arabic version of the "self-evaluation of negative symptoms" scale (SNS).
    Hajj A; Hallit S; Chamoun K; Sacre H; Obeid S; Haddad C; Dollfus S; Rabbaa Khabbaz L
    BMC Psychiatry; 2020 May; 20(1):240. PubMed ID: 32408876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.
    Martínez-Cao C; García-Álvarez L; Bobes-Bascarán T; de la Fuente-Tomás L; Fernández-Egea E; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz-Martínez PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):22-28. PubMed ID: 35256069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.